{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:04:27Z","timestamp":1783094667360,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.plefa.2006.02.002","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T15:29:05Z","timestamp":1144250945000},"page":"339-346","source":"Crossref","is-referenced-by-count":32,"title":["Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls"],"prefix":"10.1016","volume":"74","author":[{"given":"B.M.","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Hultman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-A.","family":"Wiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2006.02.002_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.plefa.2003.08.013","article-title":"Relationship between the niacin skin flush response and essential fatty acids in schizophrenia","volume":"69","author":"Messamore","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2006.02.002_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0006-3223(91)90060-Y","article-title":"Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans","volume":"29","author":"Kleijnen","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0090-6980(79)90055-8","article-title":"Prostaglandins contribute to the vasodilation induced by nicotinic acid","volume":"17","author":"Eklund","year":"1979","journal-title":"Prostaglandins"},{"key":"10.1016\/j.plefa.2006.02.002_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"10.1016\/j.plefa.2006.02.002_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.plefa.2006.02.002_bib6","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.143.9.2982","article-title":"The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells: localisation of glutathione-requiring PGD synthetase in histiocytes, dendritic and Kuppfer cells in various rat tissues","volume":"143","author":"Urade","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.plefa.2006.02.002_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-2952(02)01220-0","article-title":"G protein-coupled receptor for nicotinic acid in mouse macrophages","volume":"64","author":"Lorenzen","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2006.02.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1977.tb02116.x","article-title":"Studies on the mechanism of flush induced by nicotinic acid","volume":"41","author":"Andersson","year":"1977","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.plefa.2006.02.002_bib9","series-title":"Niacin Therapy in Schizophrenia","author":"Hoffer","year":"1962"},{"key":"10.1016\/j.plefa.2006.02.002_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2006.02.002_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-3223(99)00010-4","article-title":"Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia","volume":"46","author":"Hudson","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0006-3223(91)90202-W","article-title":"Niacin test in schizophrenia and affective illness","volume":"29","author":"Rybakowski","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib14","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0006-3223(86)90321-5","article-title":"Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics","volume":"21","author":"Fiedler","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0006-3223(86)90274-X","article-title":"Niacin skin flush test is not diagnostic of schizophrenia","volume":"21","author":"Wilson","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib16","first-page":"54","article-title":"Schizophrenia: a biochemical disorder?","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine"},{"key":"10.1016\/j.plefa.2006.02.002_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0006-3223(89)90216-3","article-title":"Essential fatty acids in plasma phospholipids in schizophrenics","volume":"25","author":"Horrobin","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0006-3223(00)00986-0","article-title":"Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group","volume":"49","author":"Assies","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archpsyc.1994.03950080077012","article-title":"Arachidonic acid: a common link in the biology of schizophrenia?","volume":"51","author":"Peet","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-9964(94)90045-0","article-title":"Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia: a preliminary report","volume":"29","author":"Ward","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"Puri","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose\u2013response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0924-977X(03)00145-7","article-title":"Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry","volume":"14","author":"Ross","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2006.02.002_bib27","first-page":"163","article-title":"Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin","volume":"43","author":"Shah","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale","volume":"37","author":"Smesny","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"Smesny","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2006.02.002_bib30","series-title":"Handbook of Psychophysiology","first-page":"200","article-title":"The electrodermal system","author":"Dawson","year":"2000"},{"key":"10.1016\/j.plefa.2006.02.002_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/cs0680433","article-title":"The human eccrine sweat gland adenylate cyclase system: response to agonists","volume":"68","author":"Khullar","year":"1985","journal-title":"Clin. Sci. (London)"},{"issue":"5 Pt 1","key":"10.1016\/j.plefa.2006.02.002_bib32","doi-asserted-by":"crossref","first-page":"C842","DOI":"10.1152\/ajpcell.1990.259.5.C842","article-title":"Regulation of Cl-permeability in normal and cystic fibrosis sweat duct cells","volume":"259","author":"Ram","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.plefa.2006.02.002_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/schbul\/10.2.204","article-title":"Psychophysiological dysfunctions in the developmental course of schizophrenic disorders","volume":"10","author":"Dawson","year":"1984","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2006.02.002_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0920-9964(01)00355-3","article-title":"What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?","volume":"54","author":"Dawson","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1037\/0021-843X.105.4.626","article-title":"Electrodermal activity and social network as predictors of outcome of episodes of schizophrenia","volume":"105","author":"Hultman","year":"1996","journal-title":"J. Abnormal Psychol."},{"key":"10.1016\/j.plefa.2006.02.002_bib36","series-title":"Progress in Electrodermal Research","first-page":"239","article-title":"Electrodermal nonresponding in first-episode psychosis as a function of stimulus significance","author":"Iacono","year":"1993"},{"key":"10.1016\/j.plefa.2006.02.002_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archpsyc.1994.03950100061006","article-title":"Autonomic abnormalities in schizophrenia","volume":"51","author":"Dawson","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2006.02.002_bib39","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, fourth ed., Washington, DC, 1994."},{"key":"10.1016\/j.plefa.2006.02.002_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1469-8986.1985.tb01626.x","article-title":"Scoring criteria for response latency and habituation in electrodermal research: a critique","volume":"22","author":"Levinson","year":"1985","journal-title":"Psychophysiology"},{"key":"10.1016\/j.plefa.2006.02.002_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-1781(95)02553-4","article-title":"Social and physical anhedonia in relation to cerebral laterality and electrodermal habituation in unmedicated psychotic patients","volume":"56","author":"Gruzelier","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2006.02.002_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1113\/jphysiol.1990.sp017950","article-title":"Chloride permeability regulation via a cyclic AMP pathway in cultured human sweat duct cells","volume":"421","author":"Pedersen","year":"1990","journal-title":"J. Physiol."},{"key":"10.1016\/j.plefa.2006.02.002_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00045391-199506000-00006","article-title":"Low-dose aspirin and ibuprofen reduce the cutaneous reactions following niacin administration","volume":"2","author":"Dunn","year":"1995","journal-title":"Am. J. Ther."},{"issue":"Suppl.","key":"10.1016\/j.plefa.2006.02.002_bib44","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1007\/BF02637085","article-title":"The significance of polyunsaturated fatty acids in cutaneous biology","volume":"31","author":"Ziboh","year":"1996","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.plefa.2006.02.002_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.1989.tb01403.x","article-title":"Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response","volume":"121","author":"Morse","year":"1989","journal-title":"Br. J. Dermatol."},{"issue":"1 Suppl.","key":"10.1016\/j.plefa.2006.02.002_bib46","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/ajcn\/71.1.367s","article-title":"Essential fatty acid metabolism and its modification in atopic eczema","volume":"71","author":"Horrobin","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2006.02.002_bib47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/1469-8986.3920124","article-title":"The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects","volume":"39","author":"Schell","year":"2002","journal-title":"Psychophysiology"},{"key":"10.1016\/j.plefa.2006.02.002_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF02247121","article-title":"Effects of neuroleptics on electrodermal activity in schizophrenic patients: a review","volume":"102","author":"Schnur","year":"1990","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.plefa.2006.02.002_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/oxfordjournals.schbul.a006891","article-title":"Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparison with controls","volume":"27","author":"Zahn","year":"2001","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2006.02.002_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(93)90250-H","article-title":"Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine","volume":"34","author":"Zahn","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2006.02.002_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","article-title":"The influence of age and gender on niacin skin test results\u2014implications for the use as a biochemical marker in schizophrenia","volume":"38","author":"Smesny","year":"2004","journal-title":"J. Psychiatr. Res."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327806000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327806000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T23:11:40Z","timestamp":1683414700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327806000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0952327806000111"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2006.02.002","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}